Scientific Advisory Board

Kaj Blennow, MD, PhD

Sahlgrenska University Hospital, Gothenburg, Sweden

Kaj Blennow MD PhD
Linkedin Logo

Professor of Clinical Neurochemistry, University of Gothenburg, Sweden

Head of Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden

  • Former researcher at the Medical Research Council (MRC), Sweden
Keith Crutcher, PhD

University of Cincinnati, Cincinnati, Ohio

Keith Crutcher PhD
Linkedin Logo

Volunteer Professor, Department of Neurosurgery, University of Cincinnati, Cincinnati, Ohio

  • Past Professor and Director of Research, Department of Neurosurgery, University of Cincinnati
  • Former Scientific Review Officer, Emerging Technologies & Training in Neuroscience, Center for Scientific Review, NIH
Murali Doraiswamy, MBBS, FRCP

Duke University School of Medicine, Durham, North Carolina

Murali Doraiswamy MBBS FRCP
Linkedin Logo

Professor of Psychiatry and Medicine (Geriatrics), Duke University School of Medicine, Durham, North Carolina

Director of the Neurocognitive Disorders, Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina

  • Member, Duke Institute for Brain Sciences
  • Member, Duke Center for Applied Genomics and Precision Medicine
  • Co-author, “The Alzheimer’s Action Plan”
Serge Gauthier, MD, FRCPC

Alzheimer’s Disease Research Unit at McGill University, Montreal, Canada

Serge Gauthier MD FRCPC
Linkedin Logo

Director of the Alzheimer’s Disease Research Unit at McGill University, Montreal, Canada

Professor of Neurology & Neurosurgery, Psychiatry and Medicine at McGill University, Montreal, Canada

  • Member, Douglas Mental Health University Institute’s Research Center
  • Membre Associé, Institut Universitaire de Gériatrie, Université de Montréal
Jakub Hort, MD, PhD, FEAN

University Hospital Motol, Prague, Czech Republic

Jakub Hort MD PhD
Linkedin Logo

Head of Memory Disorders Unit, University Hospital Motol, Prague, Czech Republic

Professor of Neurology, Charles University, Prague, Czech Republic

  • PI Czech Brain Aging Study
  • Chairman Czech Alzheimer Foundation
  • Co-founder Alzheimerchain/Terrapino mobile app
Cyril Höschl, MD, DSc, FRCPsych

Charles University, Prague, Czech Republic

Cyril Hoeschl Prof MD DSc FRCPsych
Linkedin Logo

Professor and Chairman Emeritus, Department of Psychiatry and Clinical Psychology, the Third Faculty of Medicine, Charles University, Prague

  • Founding manager and Director Emeritus of the National Institute of Mental Health, Klecany, Czech Republic
Steven Jacobsen, PhD

Creacion Ventures, Boston, MA

Creacion Ventures, Boston, MA (former WuXi Healthcare Ventures)

Adjunct Associate Professor, New York University School of Medicine, New York, New York

  • Past Chief Executive Officer, American Life Science Pharmaceuticals, La Jolla, California
  • Past Associate Editor “Current Alzheimer’s Research”
Diane Jorkasky, MD, FACP

Director at Alzheon, Inc., Framingham, Massachusetts

Diane Jorkasky MD
Linkedin Logo
  • Faculty member at UCSF, Yale, Penn and Uniformed Service of Health Sciences Medical Schools
  • Past Head of Development and Chief Medical Officer at Endo Pharmaceuticals
  • Past Vice President, Global Clinical Research Operations at Pfizer
Ara S. Khachaturian, PhD

Khachaturian and Associates, Potomac, Maryland

Ara S Khachaturian PhD
Linkedin Logo

Principal, Khachaturian and Associates, Potomac, Maryland

Executive Editor of “Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association”

  • Executive Vice-President, Campaign to Prevent Alzheimer’s Disease (PAD2020), Rockville, Maryland
  • Chair and President of the National Biomedical Research Ethics Council (NBREC), Las Vegas, Nevada
Louis Kirby, MD

ZettaScience, Inc., Scottsdale, Arizona

Louis Kirby MD
Linkedin Logo

Co-Founder, ZettaScience, Inc., Scottsdale, Arizona

Consulting Medical Director, Amarantus Bioscience Holdings, Phoenix, Arizona

  • Founder of Pivotal Research Center in Phoenix, one of the largest medical research centers in the U.S.
  • Principal investigator on nearly 400 clinical trials
Miia Kivipelto, MD, PhD

Karolinska University Hospital, Stockholm, Sweden

Miia Kivipelto MD PhD
Linkedin Logo

Director of Research and Education at the Geriatric Clinic and Head of the Unit of Clinical Trials, Karolinska Hospital, Stockholm, Sweden

Professor and Senior Geriatrician, Karolinska University Hospital, Stockholm, Sweden

  • Leading expert on Alzheimer’s risk factors, early diagnoses and disease prevention
  • Expert/member of advisory boards for industry related to dementia studies
  • Founding member of the European Dementia Prevention Initiative (EDPI)
  • Principal investigator – Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Dementia (FINGER)
William Mobley, MD, PhD

University of California, San Diego, California

William Mobley MD PhD
Linkedin Logo

Professor and Chair, Department of Neurosciences, University of California, San Diego, California

Executive Director of Down Syndrome Center for Research and Treatment at University of California, San Diego, California

  • Founding Director of the Neuroscience Institute at Stanford University
  • Fellow of the Royal College of Physicians
  • Fellow of the American Association for the Advancement of Science
Anton Porsteinsson, MD

University of Rochester School of Medicine, Rochester, New York

Anton Porsteinsson MD
Linkedin Logo

Director of Memory Disorders Clinic, University of Rochester, Rochester, New York

Professor of Psychiatry, University of Rochester School of Medicine, Rochester, New York

  • Director of Alzheimer’s Disease Care, Research and Education Program at the University of Rochester
Eric Reiman, MD

Banner Alzheimer’s Institute, Phoenix, Arizona

Eric Reiman MD

Chief Executive Officer of Banner Research and Executive Director of Banner Alzheimer’s Institute, Phoenix, Arizona

Professor of Psychiatry, University of Arizona, Tucson, Arizona

  • Director of Arizona Alzheimer’s Consortium
  • Clinical Director, Neurogenomics Division at the Translational Genomics Research Institute
Marwan N. Sabbagh, MD, FAAN

Phoenix, Arizona

Marwan Sabbagh MD FAAN
Linkedin Logo

Professor of Neurology, Phoenix, AZ

Research Professor, University of Arizona College of Medicine, Phoenix, AZ

Clinical Professor of Neurology, Creighton University, Phoenix, AZ

  • Past Clinical Professor in Department of Neuroscience, UNLV
  • Past Director of Cleveland Clinic Lou Ruvo Center for Brain Health
  • Editor-in-chief of the Neurology and Therapy journal
Carl Sadowsky, MD

Palm Beach Neurology, West Palm Beach, Florida

Carl Sadowsky MD
Linkedin Logo

Medical Director of Premiere Research Institute, Palm Beach Neurology, West Palm Beach, Florida

Clinical Professor of Neurology, Nova Southeastern University, Fort Lauderdale, Florida

  • Past Director of St. Mary’s Hospital Memory Disorders Center
John Sampalis, PhD

McGill University, Montreal, Canada

John Sampalis PhD
Linkedin Logo

CEO & Chief Scientific Officer, JSS Medical Research, Montreal, Canada

Professor of Surgery and Medicine, McGill University, Montreal, Canada

Director of Surgical Research, Jewish General Hospital, Montreal, Canada

  • Reviewer for over five leading peer reviewed journals
Katerina Sheardova, MD, PhD

International Clinical Research Center (ICRC) at St. Anne's University Hospital, Brno, Czech Republic

Katerina Sheardova MD PhD
Linkedin Logo

Head of ICRC Memory Center, Brno, Czech Republic

  • National delegate on Dementia and Cognitive Disorders panel of European Academy of Neurology
  • Co-founder of Czech Brain Aging Study – national longitudinal study on aging
  • Member of Management Board of Section on Cognitive Neurology, Czech Neurological Society
Pete Snyder, PhD

The University of Rhode Island, Kingston, Rhode Island

Pete Snyder PhD
Linkedin Logo

Professor of Biomedical and Pharmaceutical Sciences, The University of Rhode Island, Kingston, RI

  • Past Professor of Neurology, The Alpert Medical School of Brown University
  • Past Director and Early Clinical Leader of novel compounds for Alzheimer’s disease and schizophrenia at Pfizer
  • Senior Associate Editor “Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association”
Bruno Vellas, MD, PhD

University Hospital Center, Toulouse, France

Bruno Vellas MD PhD
Linkedin Logo

Chief, Alzheimer’s Disease Clinical and Research Center, University Hospital Center, Toulouse, France

Chairman of the Department of Internal and Geriatric Medicine, University Hospital Center, Toulouse, France

  • President of the International Association of Gerontology and Aging
  • Chairman of the International Academy on Nutrition and Aging
  • Editor-in-chief “The Journal of Nutrition, Health and Aging”
Michael W. Weiner, MD

San Francisco, California

Michael W Weiner MD
Linkedin Logo

Professor of Radiology and Biomedical Imaging, Medicine, Psychiatry, and Neurology, Emeritus, University of California, San Francisco, California

Principal investigator of the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the largest observational study of Alzheimer’s disease